课题基金 / 基金详情

Collagen-based implant materials with central agent depot for the therapy of bone defects

Collagen-based implant materials with central agent depot for the therapy of bone defects
用于骨缺损治疗的具有中央药剂库的胶原基植入材料
批准号:
451966134
负责人:
Professor Dr. Michael Gelinsky
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants (Transfer Project)
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Professor Dr. Michael Gelinsky的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The concept of in situ tissue engineering (TE) could open up new treatment options, e.g. for extensive or non-healing bone defects. In contrast to the classic TE, no cells are implanted, so that the costs and the approval effort for such implants are lower. The present transfer project builds on the work of sub-project M4 (Establishment of the new approach `in situ tissue engineering΄ for bone defect healing) of the completed SFB/Transregio 79 and is to further develop the concept investigated there with an application partner for use in the clinic. At the end of TR79, a biomimetic bone substitute material made of mineralized collagen has been developed, which is loaded with chemoattractive substances in a central depot. It could be shown that the concentration gradient established in an aqueous environment stimulates the migration of mesenchymal stem cells and endothelial cells into the scaffold and thus promotes defect healing compared to unmodified scaffolds.The focus of the transfer project is now (1) the transfer of scaffold production to clinically approved, equine collagen and the development of an industrially feasible process chain, (2) the investigation of alternative depot components for controlled drug release with the aim of expanding the range of applications of the drug-containing implants, (3) the exploration of new, suitable strategies for the introduction of the drug depot, (4) the study of the sterilisability and shelf life of implants containing the drug deposit, (5) the standardization of the production of chemoattractive drug mixtures from hypoxia-conditioned medium and (6) the testing of the usability of the scaffold system for the local release of antibiotics. A respected manufacturer of collagen-based medical devices was won as an application partner.The transfer project is based on solid preparatory work and a large number of publications that have resulted from the work in the SFB/TR 79
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New generation of 3D scaffolds for patient-specific therapies in orthopedic applications
Biodegradable and elastic flock scaffolds from a single material system based on chitosan for articular cartilage regeneration
Hierarchically structured biphasic scaffolds mimicking osteochondral tissue
Flocktechnologisch erzeugte Scaffolds für das Tissue Engineering
国内基金
海外基金
Data-driven Recommendation System Construction of an Online Medical Platform Based on the Fusion of Information
Incentive and governance schenism study of corporate green washing behavior in China: Based on an integiated view of econfiguration of environmental authority and decoupling logic
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    YU BYUNGJUN
  • 依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
  • 批准号:
    W2433169
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI ZHANG
  • 依托单位:
含Re、Ru先进镍基单晶高温合金中TCP相成核—生长机理的原位动态研究
  • 批准号:
    52301178
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    夏万顺
  • 依托单位: